Most Recent

image: Tumor Snipers

Tumor Snipers

By | November 1, 2012

After two headline successes, companies rush to develop “smart bomb” cancer drugs.

0 Comments

image: Exit Strategy

Exit Strategy

By | November 1, 2012

Large RNA-protein packets use a novel mechanism to escape the cell nucleus.

0 Comments

image: Life Sciences Salary Survey 2012

Life Sciences Salary Survey 2012

By | November 1, 2012

Researcher salaries continue to buck the trend of the millennium’s first decade, remaining flat or even declining across most life science disciplines.

2 Comments

image: Life Science Salaries

Life Science Salaries

By | November 1, 2012

Check out the breakdown of this year's Salary Survey data, including how compensation differs between sex, sector, and state.

0 Comments

image: Long and Rocky Roads

Long and Rocky Roads

By | November 1, 2012

From basic research to beneficial therapies

0 Comments

image: Metabolomics Sheds Light on TB Drug

Metabolomics Sheds Light on TB Drug

By | November 1, 2012

Understanding the mechanism of a classic tuberculosis treatment could refine future strategies for TB drug development.

1 Comment

image: A Window into Cancer

A Window into Cancer

By | October 31, 2012

Researchers implant a glass pane in the abdominal walls of living mice to watch cancer cells metastasize to the liver.

2 Comments

image: Fair Flu Viruses Closely Matched

Fair Flu Viruses Closely Matched

By | October 30, 2012

A study finds that the genomes of swine and human flu viruses associated with a county fair in Ohio are almost perfectly matched, suggesting interspecies transmission.

0 Comments

image: mRNA Not Equal in All Cells

mRNA Not Equal in All Cells

By | October 26, 2012

Scientists identify a false assumption of standard gene expression analyses that could lead to the reappraisal of many prior studies.

5 Comments

image: Viruses Affect Cell Reprogramming

Viruses Affect Cell Reprogramming

By | October 25, 2012

Viral vectors used to carry transcription factors that de-differentiate cells into a stem-cell-like state are themselves a key factor in efficient reprogramming.

6 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech